Simona Skerjanec

This inventor holds 15 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Cardiovascular Therapies. Top assignees: Chiesi Farmaceutici S.p.a., The Medicines Company. Active years: 2014-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simona Skerjanec. Retrieved from https://idiyas.com/inventor/simona-skerjanec

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.6

ph-index = 7

Forward Citations = 338(Granted Patents)

Location History:

Pittstown, NJ (US) (2014)
Basel, CH (2014 - 2023)

Company Filing History:

9 out of 343

Chiesi Farmaceutici S.p.a.

patents

6 out of 26

The Medicines Company

patents

Years Active: 2014-2023

Loading Chart...

Areas of Expertise:

Ischemic Events

Platelet Inhibition

Antiplatelet Therapy

Stent Thrombosis

Cardiovascular Treatment

Therapeutic Methods

Event Prevention

Clinical Applications

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11633419 - Methods of treating, reducing the incidence of, and/or preventing ischemic events (2023-04-25),

2. 11510934 - Maintenance of platelet inhibition during antiplatelet therapy (2022-11-29),

3. 11351187 - Methods of treating, reducing the incidence of, and/or preventing ischemic events (2022-06-07),

4. 11147879 - Methods of treating or preventing stent thrombosis (2021-10-19),

5. 10744149 - Maintenance of platelet inhibition during antiplatelet therapy (2020-08-18),

6. 10376532 - Methods of treating, reducing the incidence of, and/or preventing ischemic events (2019-08-13),

7. 10231987 - Maintenance of platelet inhibition during antiplatelet therapy (2019-03-19),

8. 10022391 - Maintenance of platelet inhibition during antiplatelet therapy (2018-07-17),

9. 9925265 - Methods of treating or preventing stent thrombosis (2018-03-27),

10. 9427448 - Methods of treating, reducing the incidence of, and/or preventing ischemic events (2016-08-30),

11. 9320754 - Maintenance of platelet inhibition during antiplatelet therapy (2016-04-26),

12. 8871736 - Maintenance of platelet inhibition during antiplatelet therapy (2014-10-28),

13. 8759316 - Maintenance of platelet inhibition during antiplatelet therapy (2014-06-24),

14. 8716261 - Maintenance of platelet inhibition during antiplatelet therapy (2014-05-06),

15. 8680052 - Methods of treating, reducing the incidence of, and/or preventing ischemic events (2014-03-25),

Title: The Innovative Journey of Simona Skerjanec

Introduction: Simona Skerjanec is a pioneering inventor based in Basel, Switzerland, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Simona Skerjanec holds several patents in the area of personalized medicine, with her most recent patent focusing on a novel method for early detection of genetic diseases.

Career Highlights: With a background in molecular biology and genetics, Simona Skerjanec has dedicated her career to developing innovative solutions that have the potential to revolutionize healthcare practices worldwide. Her work has been recognized for its significant impact on improving patient outcomes and advancing the field of precision medicine.

Collaborations: Throughout her career, Simona Skerjanec has collaborated with leading research institutions and biopharmaceutical companies to further her research and bring her inventions to market. Her collaborative efforts have resulted in the successful development of cutting-edge diagnostic tools and therapeutic interventions.

Conclusion: Simona Skerjanec's relentless pursuit of innovation and commitment to improving healthcare through her inventions make her a trailblazer in the field of biotechnology. Her work continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of personalized medicine.

Profile summary based on public USPTO records.